A RevSC signature, that includes CLU, has been confirmed in human colorectal tumours and, similarly to what has been observed in the mouse intestine, it appears to be largely mutually exclusive with the LGR5+ve stem cell signature [49]. This evidence concerns the gene LGR5 and colorectal neoplasm.